Skip to content
NEJM Interviews cover art

All Episodes

NEJM Interviews — 958 episodes · page 6 of 10

#
Title
501

NEJM Interview: Dr. Benjamin Sommers on increased pressure on state Medicaid programs caused by Covid-19 and policies for strengthening Medicaid.

502

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on diagnosis and early treatment of Covid-19

503

NEJM Interview: Dr. Erin Fraher on opportunities for expanding health workforce capacity during the Covid-19 pandemic.

504

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on new data on remdesivir in Covid-19

505

NEJM Interview: Dr. Lisa Rosenbaum on how health care workers have responded to the challenges of caring for patients during the Covid-19 pandemic.

506

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on capitalizing on immune responses to Covid-19

507

NEJM Interview: Dr. Nicole Lurie on rapid vaccine development, including new tools to facilitate vaccine testing and manufacturing and persistent challenges.

508

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on finding reliable information about Covid-19

509

NEJM Interview: Dr. Marco Vergano on caring for critically ill patients with Covid-19 and resource allocation in the ICU.

510

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on studying potential Covid-19 therapies

511

NEJM Interview: Prof. Rachel Sachs on the Trump administration’s proposal to allow states to develop programs to import prescription drugs from Canada.

512

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on Loosening Covid-19 Restrictions

513

NEJM Interview: Dr. Judd Hollander on how health systems can use telemedicine services during the Covid-19 pandemic.

514

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on approaches to Covid-19 vaccines and antivirals.

515

NEJM Interview: Dr. William Shrank on the management of clinical and social risk factors in quality-assessment and payment programs.

516

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on caring for patients with Covid-19.

517

NEJM Interview: Dr. Amy Finkelstein on the use of evidence from randomized, controlled trials to answer questions about health care policy.

518

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on emerging tools in the fight against Covid-19.

519

NEJM Interview: Prof. Michelle Mello on health professionals’ moral duty to intervene in response to sexual harassment and gender bias.

520

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on lessons from Covid-19 hotspots.

521

NEJM Interview: Dr. Nora Volkow on stigma against people who use drugs and its effects on care delivery and the burden of substance use disorders.

522

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on practical measures to help prevent Covid-19.

523

NEJM Interview: Prof. Erin Fuse Brown on Congress’s failure to address surprise medical bills in 2019 and renewed efforts in 2020.

524

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on new research on possible treatments for Covid-19.

525

NEJM Interview: Dr. William Haseltine on lessons from Egypt’s screening for hepatitis C in the context of its universal disease screening and treatment program.

526

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on making decisions about Covid-19 testing and treatment for your patients.

527

NEJM Interview: Dr. Mariana Socal on draft guidance from the FDA aimed at promoting competition in the insulin market.

528

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on what clinicians need to know in diagnosing and treating Covid-19.

529

NEJM Interview: Roosa Tikkanen on patterns of social spending in the United States and other high-income countries.

530

NEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on preparing for the spread of Covid-19.

531

NEJM Interview: Dr. Mark Travassos on preventing the spread of influenza among detained migrants and asylum seekers.

532

NEJM Interview: Dr. David Christiani on the epidemic of vaping by young people and related severe lung injuries.

533

NEJM Interview February 14, 2020: Dr. Eric Rubin and Dr. Lindsey Baden on SARS-CoV-2 and Covid-19: redefining the disease.

534

NEJM Interview February 7, 2020: Dr. Eric Rubin and Dr. Lindsey Baden on what physicians need to know about the current 2019 Novel Coronavirus outbreak.

535

NEJM Interview: Dr. Bianca Frogner on scope-of-practice regulations and how they can be redesigned to better serve the needs of patients.

536

NEJM Interview: Dr. Joshua Mezrich on the dead-donor rule and how it affects donation of organs in the United States and Canada.

537

NEJM Interview: Dr. Ruma Rajbhandari on the need for increased investment in district hospitals in low- and lower-middle-income countries.

538

NEJM Interview: Dr. Karthik Sivashanker on leveraging models from patient-safety efforts to increase equity.

539

NEJM Interview: Dr. Dominique Béhague on therapeutic strategies that rely on bidirectional critical analysis and learning.

540

NEJM Interview: Dr. David Cutler on the debate over Medicare for All and other proposals for reforming the U.S. health care system.

541

NEJM Interview: Drs. James Shultz and Krista Nottage on climate-change–driven storms and their disproportionate effects on marginalized populations.

542

NEJM Interview: Dr. Dhruv Kazi on a new California law aimed at increasing use of preexposure prophylaxis by people at heightened risk for acquiring HIV infection

543

NEJM Interview: Dr. Michele Friedner on how the concept of normality affects health care decisions.

544

NEJM Interview: Dr. Adewole Adamson on the role of machine learning in cancer diagnosis.

545

NEJM Interview: Dr. Goudarz Molaei on range expansion of the lone star tick and other tick species and implications for human health.

546

NEJM Interview: Dr. Peter J. Campbell on genome sequencing in cancer.

547

NEJM Interview: Dr. Jonathan Oberlander on legislation aimed at reducing spending on prescription drugs.

548

NEJM Interview: Dr. Ippolytos Kalofonos on the gatekeeper role played by U.S. physicians in facilitating vulnerable patients’ access to disability benefits.

549

NEJM Interview: Dr. Kevin De Cock on the research and public health benefits of autopsies and other forms of postmortem investigation.

550

NEJM Interview: Dr. Michael Fralick on contributors — and proposed solutions — to high insulin prices in the United States.

551

NEJM Interview: Dr. Caleb Gardner on the limitations of an increasing focus on biologic knowledge in psychiatry.

552

NEJM Interview: Dr. Lakshmi Ganapathi on threats to medical deferred action.

553

NEJM Interview: Dr. Yogesh Jain on the production of medical evidence that can benefit people in lower-resource settings.

554

NEJM Interview: Dr. Stacie Dusetzina on three proposals for redesigning the Medicare Part D prescription-drug benefit.

555

NEJM Interview: Prof. Tara Sklar on recent state laws creating prescription-drug affordability boards.

556

NEJM Interview: Dr. Benard Dreyer on government policies and actions that build on a legacy of antiimmigrant sentiment in the United States.

557

NEJM Interview: Dr. Robert Aronowitz on how the largely social processes by which we identify diseases can transform diseases themselves.

558

NEJM Interview: Dr. Debra Weinstein on policies related to parenting during medical training that could be implemented at the national, institutional, and program levels.

559

NEJM Interview: Dr. Ida Sim on mobile devices and health.

560

NEJM Interview: Dr. Michael Baden on deaths of women due to complications from illegal abortion attempts.

561

NEJM Interview: Dr. Catherine Lucey on the identification and treatment of opioid use disorder in medical students.

562

NEJM Interview: Dr. Renee Salas on the effects of climate change on human health and health systems.

563

NEJM Interview: Dr. Kelly Knight on reproductive injustice and actions clinicians can take to prevent disparities in reproductive health outcomes

564

NEJM Interview: Elizabeth Nash on state-level abortion restrictions, including recent efforts that directly challenge Roe v. Wade.

565

NEJM Interview: Dr. Katherine A. High on gene therapy for genetic disease.

566

NEJM Interview: Dr. Deborah Anderson on the potential for new contraceptive methods to ease problems associated with population growth.

567

NEJM Interview: Dr. Pieter Cohen on the legal status of cannabidiol and an opportunity to strengthen the FDA’s approach to safety requirements for new dietary ingredients.

568

NEJM Interview: Dr. Anita Berlin on the relationship between the state and medical care and maintaining the integrity of the medical code of ethics.

569

NEJM Interview: Dr. Julie Cantor on steps taken by local governments to control the spread of measles.

570

NEJM Interview: Dr. Evan E. Eichler on genetic variation, comparative genomics, and the diagnosis of disease.

571

NEJM Interview: Dr. Roy Perlis on esketamine as an option for treatment-resistant depression.

572

NEJM Interview: Dr. Jonathan Oberlander on the latest legal challenge to the Affordable Care Act and the ongoing health policy stalemate in Washington.

573

NEJM Interview: Dr. Héctor Carrasco on strategies for uncovering and addressing the fundamental causes of complex health problems.

574

NEJM Interview: Dr. Deborah Dowell on concerns about misimplementation and misapplication of the CDC’s opioid-prescribing guideline.

575

NEJM Interview: Dr. Michael F. Clarke on clinical and therapeutic implications of cancer stem cells.

576

NEJM Interview: Dr. Anthony Fauci on troubling increases in measles cases in the United States and globally.

577

NEJM Interview: Dr. Sanjeev Krishna on delays in parasite clearance observed in patients with malaria treated with artesunate.

578

NEJM Interview: Dr. Wafaa El-Sadr on an ambitious new HIV goal for the United States and lessons to be learned from the global HIV response.

579

NEJM Interview: Dr. Daphna Stroumsa on the limitations of classification systems in health care and their potential effects on patients.

580

NEJM Interview: Dr. Jeremy Farrar on the emergence and spread of new infectious diseases and ensuring swift, coordinated action in the face of threats.

581

NEJM Interview: Dr. Scott Podolsky on the revolution in pharmaceutical marketing that set the stage for physician “education” about treating pain with opioids.

582

NEJM Interview: Dr. Helen Blau on stem cells in the treatment of disease.

583

NEJM Interview: Dr. Matthew Fiedler on policies for extending coverage to the remaining uninsured populations in the United States.

584

NEJM Interview: Dr. J. Brian Byrd on the recall of products containing angiotensin-receptor blockers and the implications for patient care.

585

NEJM Interview: Dr. David Ansell on racial disparities in health that result from unequal distribution of power and resources.

586

NEJM Interview: Terry Langbaum and Dr. Tom Smith on issues faced by long-term survivors with metastatic cancer.

587

NEJM Interview: Dr. Isaac Kohane on machine learning in medicine.

588

NEJM Interview: Dr. Ingrid Binswanger on gaps in treatment for opioid use disorder for people who are incarcerated.

589

NEJM Interview: Dr. Laszlo Madaras on caring for people who diverge from the typical patient imagined by health care institutions.

590

NEJM Interview: Dr. Cynthia Chuang on federal efforts to weaken the ACA’s contraceptive-coverage mandate.

591

NEJM Interview: Dr. Matthew H. Porteus on therapeutic editing of the human genome.

592

NEJM Interview: Dr. George Daley on the prospects for using genome editing to prevent genetic diseases.

593

NEJM Interview: Dr. Kenneth Poole on the challenges involved in interpreting patient-experience ratings, including bias against black physicians.

594

Audio roundtable discussion on learning to foster better teams.

595

NEJM Interview: Dr. Scott Stonington on structures within medicine that may systematically harm patients.

596

NEJM Interview: Prof. Mark Hall on strategies for addressing inadequate provider networks and surprise medical bills.

597

NEJM Interview: Dr. Benjamin S. Freedman on organoids as preclinical models of human diseases.

598

NEJM Interview: Drs. Jeffrey Drazen and Lisa Rosenbaum on finding meaning and connecting with patients in modern medical practice.

599

NEJM Interview: Dr. Megan Ranney on the #ThisIsOurLane movement and health care professionals’ role in advocating for solutions to the gun violence epidemic.

600

Dr. Ameya Kulkarni on drivers of physician loneliness and opportunities for meaningful interaction.